Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for quality control of injections for treating thromboangitis diseases

A quality control method and thrombus occlusion technology, applied in the field of medicine, can solve the problems of insufficient product quality control and other problems

Active Publication Date: 2007-03-14
JINLING PHARMA
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Currently clinically used Mailuoning Injection adopts quality control standards. The identification includes the identification of chlorogenic acid and bisartemisinic acid. In terms of content determination, only the content of cinnamic acid is used to control the quality of the product, which is not enough for product quality control. comprehensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for quality control of injections for treating thromboangitis diseases
  • Method for quality control of injections for treating thromboangitis diseases
  • Method for quality control of injections for treating thromboangitis diseases

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0043] Experimental Example 1: Methodological Research on Fingerprints

[0044] Stability test: Take the same part of the test solution and detect it at different times to investigate the consistency of the chromatographic peak retention time and peak area ratio. The results are shown in Table 1 and Table 2. internal stability.

[0045] peak number

[0046] peak number

[0047] Precision test: take the same test solution, inject 6 times continuously, and investigate the consistency of relative retention time and peak area ratio of chromatographic peaks. The results are shown in Table 3 and Table 4. It is stipulated that for each chromatographic peak with a common peak area ratio, the relative standard deviation of the peak area ratio is less than 3%.

[0048] peak number

[0049]

[0050] Reproducibility experiment: Take the injection of the same batch number, prepare 6 copies of the test product in parallel, and test them. The result...

experiment example 2

[0053] Experimental Example 2: Research on Fingerprint and Various Technical Parameters

[0054] Fingerprint: Figure 1 is the fingerprint and various technical parameters of Mailuoning Injection, Figure 2 is the blank baseline spectrum, Figure 3 is the reference spectrum, and Figure 4 is the fingerprint of Mailuoning Injection recorded for 2 hours.

[0055] Calibration of common peaks: According to the detection results of 10 batches of test samples, 10 chromatographic peaks common to each batch of samples with relatively stable retention time and peak area were selected as the common peaks of the fingerprint of Mailuoning injection. The sum accounts for more than 95% of the peak area. After HPLC / MS analysis, the four peaks were preliminarily determined to be 5-hydroxymethylfurfural (peak No. 1), chlorogenic acid (peak No. 3), caffeic acid (peak No. 4), and cinnamic acid (peak No. 10). .

[0056] The ratio of the common peak area: the relative retention time detection result...

experiment example 3

[0061] Experimental Example 3: Correlation Study of Fingerprints of Injections, Intermediates and Chinese Medicinal Materials

[0062] Using HPLC / DAD / MS technology, we investigated the correlation between Mailuoning Injection, intermediates and medicinal materials. The results showed that Mailuoning Injection had a good correlation with its intermediates, while Dendrobium , Scrophulariaceae and honeysuckle four medicinal materials are reflected in the injection and intermediates, the results are shown in Table 10.

[0063] t R (min)

[0064] According to the injection preparation process, injections containing only single medicinal materials were extracted and prepared. Measure 1.0ml of the single medicinal material injections into 10ml measuring bottles, add water to dilute to the mark, shake well, and use a 0.45um microporous filter membrane Filtration, as the test solution.

[0065] A%(V / V)

[0066] The detection wavelength is 300nm for the fingerpr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention discloses one quality control method to diagnose thrombus obdurate disease Mailuoning injection liquid, which comprises the fingerprint spectrum test and the content test of chlorogenic acid and cinnamic acid. Comparing with the original quality control standard, this invention can make the total quality control on the injection liquid.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a quality control method of Mailuoning injection for treating thrombotic occlusive diseases, which uses plant crude drugs Achyranthes bidentata, Scrophulariaceae, dendrobium and honeysuckle as raw materials. Background technique [0002] Currently clinically used Mailuoning Injection adopts quality control standards. The identification includes the identification of chlorogenic acid and bisartemisinic acid. In terms of content determination, only the content of cinnamic acid is used to control the quality of the product, which is not enough for product quality control. comprehensive. The present invention adds the determination of fingerprints and the content of total chlorogenic acid, and changes the conditions for the determination of cinnamic acid content. Compared with the original quality control standard, it can carry out comprehensive quality control on the injection, so it...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/34G01N30/36G01N30/02G01N30/06
Inventor 王兴旺徐向阳万辉张庆晓张蕙陈钟张杰陈希孙晔田丽娟倪洁蔡莹王伟张春来谢俊张晓静夏云范廷校杨俊许剑锋
Owner JINLING PHARMA